Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodarone

J Electrocardiol. 1997 Apr;30(2):147-9. doi: 10.1016/s0022-0736(97)80024-6.

Abstract

Cardiac hemochromatosis can cause heart failure and cardiac arrhythmias. Among these arrhythmias, ventricular tachycardia may be resistant to treatment. A case of cardiac hemochromatosis complicated with ventricular tachycardia that did not respond to intravenous lidocaine, procainamide or propafenone, nor to DC cardioversion, was successfully treated with amiodarone. Amiodarone, a class III antiarrhythmic drug, may be highly effective in similar cases.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Amiodarone / therapeutic use*
  • Anti-Arrhythmia Agents / therapeutic use*
  • Biopsy
  • Cardiomyopathies / complications*
  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / physiopathology
  • Electrocardiography
  • Hemochromatosis / complications*
  • Hemochromatosis / diagnosis
  • Hemochromatosis / physiopathology
  • Humans
  • Male
  • Tachycardia, Ventricular / drug therapy*
  • Tachycardia, Ventricular / etiology
  • Tachycardia, Ventricular / physiopathology

Substances

  • Anti-Arrhythmia Agents
  • Amiodarone